Position in CDXS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$2,888,745
+$1,664,338 QoQ
Shares Held
1,278,206
+70.2% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 31 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. CDXS ranks #42 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in CDXS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,888,745 | 1,278,206 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,224,407 | 751,170 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $923,471 | 566,547 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $570,845 | 233,953 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $560,460 | 229,697 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,620,154 | 602,288 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,373,111 | 287,864 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,398,601 | 1,103,442 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,772,128 | 894,235 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $5,084,019 | 1,456,739 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $4,443,053 | 1,456,739 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $3,314,007 | 1,753,443 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,910,834 | 682,441 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $5,016,135 | 1,211,627 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $4,235 | 908,763 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $2,985,652 | 492,682 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $15,575,201 | 1,489,025 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $12,206,359 | 591,967 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $18,227,095 | 582,894 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $12,322,124 | 529,756 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $13,434,842 | 592,888 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $7,583,228 | 331,290 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $9,712,167 | 444,900 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $6,602,951 | 562,432 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $6,728,052 | 590,180 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $6,174,035 | 553,229 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||